Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Real-Time Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01833 PA GOODDOCTOR
RTNominal up57.100 +1.200 (+2.147%)
Others

14/11/2019 10:41

{I-bank focus}Daiwa raises PA Good Doctor (01833) to HK$62

[ET Net News Agency, 14 November 2019] Daiwa Research raised its target price for Ping
An Healthcare and Technology (Good Doctor)(01833) to HK$62 from HK$60 and maintained its
"buy" rating.
The research house said PA Good Doctor launched "Private Doctor" product in June, which
offers proactive online medical consultation and comprehensive offline services (such as
fast-track appointments and outpatient escort). This product has a higher ASP (CNY500,
versus "Health 360": CNY199) and decent margin (40-50%), and targets out-of-pocket
medical payments. The current backlog for "Private Doctor" reached CNY300m and revenue
will be gradually recognised over 1-year horizon.
Daiwa cut its 2021 EPS estimates by 8%, mainly due to slower-than-expected growth
momentum in the health mall segment. (KL)

Remark: Real time quote last updated: 13/12/2019 09:28
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2019 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.